Matches in SemOpenAlex for { <https://semopenalex.org/work/W1997644768> ?p ?o ?g. }
- W1997644768 endingPage "43" @default.
- W1997644768 startingPage "38" @default.
- W1997644768 abstract "The teratogenic effects of thalidomide have been studied for more than 50 years. However, there have been few studies of the pharmacokinetic changes occurring during thalidomide therapy. Thalidomide was originally developed as a sedative. However, thalidomide induces multiple birth defects when used in pregnant women. Thalidomide is now used in the treatment of multiple myeloma (MM) and erythema nodosum leprosum (ENL) in Japan. Rational use of thalidomide is problematic due to a lack of basic research regarding its mechanism of action and serum concentration/effect relationships. There are a number of hypotheses for pharmacokinetic changes in thalidomide therapy. Genetic factors including single nucleotide polymorphisms (SNPs) that change cytochrome P450 (CYP) activity and epigenetic regulation that modifies CYP expression levels may contribute to the changes in pharmacokinetics and adverse drug reactions (ADRs) of thalidomide. Environmental factors include the pharmacological context of drug-drug interactions and the physiological context of liver diseases. Liver and kidney diseases do not play important roles in pharmacokinetic changes or ADRs in thalidomide therapy. To date, most research has focused on teratogenic activity, while the impact of polymorphisms in genes encoding drug metabolic enzymes and drug-drug interactions could mediate ADRs. Here, we discuss clinical evidence of pharmacokinetic changes in thalidomide therapy." @default.
- W1997644768 created "2016-06-24" @default.
- W1997644768 creator A5007929094 @default.
- W1997644768 creator A5032900440 @default.
- W1997644768 creator A5048279225 @default.
- W1997644768 creator A5064481842 @default.
- W1997644768 creator A5076783172 @default.
- W1997644768 creator A5078922881 @default.
- W1997644768 date "2013-01-01" @default.
- W1997644768 modified "2023-10-16" @default.
- W1997644768 title "Clinical Evidence of Pharmacokinetic Changes in Thalidomide Therapy" @default.
- W1997644768 cites W1512768650 @default.
- W1997644768 cites W1563894087 @default.
- W1997644768 cites W1592762997 @default.
- W1997644768 cites W1947748380 @default.
- W1997644768 cites W1967808673 @default.
- W1997644768 cites W1968589357 @default.
- W1997644768 cites W1978425388 @default.
- W1997644768 cites W1979195900 @default.
- W1997644768 cites W1980084462 @default.
- W1997644768 cites W1985658104 @default.
- W1997644768 cites W1985830958 @default.
- W1997644768 cites W1994394328 @default.
- W1997644768 cites W1994459671 @default.
- W1997644768 cites W1997952190 @default.
- W1997644768 cites W2001056486 @default.
- W1997644768 cites W2008443801 @default.
- W1997644768 cites W2008552783 @default.
- W1997644768 cites W2008684764 @default.
- W1997644768 cites W2009084622 @default.
- W1997644768 cites W2012589701 @default.
- W1997644768 cites W2013275771 @default.
- W1997644768 cites W2018076602 @default.
- W1997644768 cites W2025580807 @default.
- W1997644768 cites W2030742912 @default.
- W1997644768 cites W2034598308 @default.
- W1997644768 cites W2041167176 @default.
- W1997644768 cites W2043867348 @default.
- W1997644768 cites W2046580571 @default.
- W1997644768 cites W2047226165 @default.
- W1997644768 cites W2054023900 @default.
- W1997644768 cites W2062080356 @default.
- W1997644768 cites W2069882255 @default.
- W1997644768 cites W2071983241 @default.
- W1997644768 cites W2080851186 @default.
- W1997644768 cites W2081446774 @default.
- W1997644768 cites W2090335671 @default.
- W1997644768 cites W2091867338 @default.
- W1997644768 cites W2093544430 @default.
- W1997644768 cites W2093857018 @default.
- W1997644768 cites W2101606846 @default.
- W1997644768 cites W2113101033 @default.
- W1997644768 cites W2114407565 @default.
- W1997644768 cites W2123175537 @default.
- W1997644768 cites W2126925854 @default.
- W1997644768 cites W2127043215 @default.
- W1997644768 cites W2127206962 @default.
- W1997644768 cites W2129422676 @default.
- W1997644768 cites W2136226957 @default.
- W1997644768 cites W2160165070 @default.
- W1997644768 cites W2165212866 @default.
- W1997644768 cites W2165580591 @default.
- W1997644768 cites W2167966824 @default.
- W1997644768 cites W2319663186 @default.
- W1997644768 doi "https://doi.org/10.2133/dmpk.dmpk-12-rv-089" @default.
- W1997644768 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23165864" @default.
- W1997644768 hasPublicationYear "2013" @default.
- W1997644768 type Work @default.
- W1997644768 sameAs 1997644768 @default.
- W1997644768 citedByCount "10" @default.
- W1997644768 countsByYear W19976447682014 @default.
- W1997644768 countsByYear W19976447682015 @default.
- W1997644768 countsByYear W19976447682016 @default.
- W1997644768 countsByYear W19976447682020 @default.
- W1997644768 countsByYear W19976447682021 @default.
- W1997644768 countsByYear W19976447682022 @default.
- W1997644768 crossrefType "journal-article" @default.
- W1997644768 hasAuthorship W1997644768A5007929094 @default.
- W1997644768 hasAuthorship W1997644768A5032900440 @default.
- W1997644768 hasAuthorship W1997644768A5048279225 @default.
- W1997644768 hasAuthorship W1997644768A5064481842 @default.
- W1997644768 hasAuthorship W1997644768A5076783172 @default.
- W1997644768 hasAuthorship W1997644768A5078922881 @default.
- W1997644768 hasConcept C104317684 @default.
- W1997644768 hasConcept C112705442 @default.
- W1997644768 hasConcept C126322002 @default.
- W1997644768 hasConcept C135763542 @default.
- W1997644768 hasConcept C151730666 @default.
- W1997644768 hasConcept C2776364478 @default.
- W1997644768 hasConcept C2779343474 @default.
- W1997644768 hasConcept C2779609412 @default.
- W1997644768 hasConcept C2780035454 @default.
- W1997644768 hasConcept C54355233 @default.
- W1997644768 hasConcept C71924100 @default.
- W1997644768 hasConcept C86803240 @default.
- W1997644768 hasConcept C92137452 @default.
- W1997644768 hasConcept C98274493 @default.
- W1997644768 hasConceptScore W1997644768C104317684 @default.